Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel

Docetaxel is a cornerstone treatment for metastatic, castration resistant prostate cancer (CRPC) which remains a leading cause of cancer-related deaths, worldwide. The clinical usage of docetaxel has resulted in modest gains in survival, primarily due to the development of resistance. There are curr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kharaziha, Pedram, Chioureas, Dimitris, Rutishauser, Dorothea, Baltatzis, George, Lennartsson, Lena, Fonseca, Pedro, Azimi, Alireza, Hultenby, Kjell, Zubarev, Roman, Ullén, Anders, Yachnin, Jeffrey, Nilsson, Sten, Panaretakis, Theocharis
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673300/
https://ncbi.nlm.nih.gov/pubmed/25844599
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados